Market Overview:
The global drug-device combination products market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in drug-device combination products. Based on type, the global drug-device combination products market is segmented into drug eluting stents, photosensitizers, orthopaedic products, infusion pumps, wound care products, inhalers,, transdermal patches and others. Drug eluting stents are expected to account for the largest share of the global market in 2018 owing to their high adoption rates for treatment of cardiovascular diseases. Based on application, the global market is segmented into cardiovascular applications (coronary artery disease (CAD), peripheral artery disease (PAD), heart failure) and non-cardiovascular applications (urological disorders such as benign prostatic hyperplasia (BPH), cancer treatment such as chemotherapy and radiation therapy). The cardiovascular application segment is expected to dominate the global market during the forecast period owing to increasing incidence of CAD and PAD across all regions.
Product Definition:
A drug-device combination product is a product that consists of one or more drugs and one or more devices. The drugs and devices can be administered separately (e.g., the drug is taken orally and the device is used to measure blood pressure) or they can be administered together (e.g., the drug is injected into a vein using a syringe with attached needle).
The important thing to remember about drug-device combination products is that they are regulated by both the FDA Center for Drug Evaluation and Research (CDER) and the FDA Center for Devices and Radiological Health (CDRH). This means that companies developing these products need to submit two separate applications—one for each center—and receive approval from both centers before their product can be marketed.
Drug Eluting Stents:
Drug eluting stents are used to treat coronary artery disease by reducing the hardening and narrowing of arteries. They are also used in treating peripheral vascular diseases, which include conditions such as aneurysms, atherosclerosis, and carotid artery disease.
Photosensitizers:
A photosensitizers is a chemical that absorbs light and becomes reactive when hit with oxygen. They are used in combination with drugs or other chemicals to make them sensitive to light. Some of the most common types of photosensitizers include aminolevulinic acid, 5-aminolevulinic acid, and 4-hydroxytoluene.
Application Insights:
The cardiovascular segment dominated the global market in terms of revenue as well as application. This is due to the high prevalence of Cardiovascular Diseases (CVDs) globally, which require treatment with drug-eluting stents and other similar products for successful management. According to a study published by WHO in 2015, it was estimated that around 31 million people died from CVDs globally. Furthermore, another study reported that around 1 in 3 deaths were caused by CVDs worldwide. Thus, increasing incidences of these diseases across the globe are expected to boost demand for combination drug-device products over the forecast period.
Non-cardiovascular applications include urological and bone treatment segments owing to rising incidence rates for urinary disorders and osteoporosis respectively across various regions including North America, Europe, Asia Pacific and Middle East & Africa over recent years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising healthcare expenditure are some of the factors responsible for its growth. In addition, increasing prevalence of chronic diseases such as cardiovascular diseases (CVDs), diabetes, and orthopedic conditions is expected to drive this market over the forecast period.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The number of people suffering from chronic diseases such as diabetes, heart disease, and cancer is on the rise, which is expected to drive the demand for drug-device combination products in the coming years.
- Technological advancements: Drug-device combination products are becoming increasingly popular due to their ability to offer better treatment outcomes than standalone drugs or devices. In addition, technological advancements are making it possible to develop smaller and more efficient drug-device combinations that can be used in a variety of settings. This is likely to boost demand for these products in the coming years.
- Growing awareness about benefits: There has been a growing awareness among healthcare professionals and patients about the benefits offered by drug-device combination products over standalone drugs or devices. This has led to an increase in demand for these products across all regions worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug-Device Combination Products Market Research Report
By Type
Drug Eluting Stents, Photosensitizers, Orthopaedic products, Infusion Pumps, Wound Care Products, Inhalers, Transdermal Patches , Others
By Application
Cardiovascular, Non-Cardiovascular, Urological, Bone Treatment, Antimicrobial treatment, Cancer Treatment, Ophthalmic Treatment , Diabetes Treatment
By Companies
Abbott, Boston Scientific Corporation, Cook Medical, Medtronic, Smith & Nephew, St. Jude Medical, Stryker Corporation, Zimmer, Ethicon, C.R. Bard
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Drug-Device Combination Products Market Report Segments:
The global Drug-Device Combination Products market is segmented on the basis of:
Types
Drug Eluting Stents, Photosensitizers, Orthopaedic products, Infusion Pumps, Wound Care Products, Inhalers, Transdermal Patches , Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Non-Cardiovascular, Urological, Bone Treatment, Antimicrobial treatment, Cancer Treatment, Ophthalmic Treatment , Diabetes Treatment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Boston Scientific Corporation
- Cook Medical
- Medtronic
- Smith & Nephew
- St. Jude Medical
- Stryker Corporation
- Zimmer
- Ethicon
- C.R. Bard
Highlights of The Drug-Device Combination Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Eluting Stents
- Photosensitizers
- Orthopaedic products
- Infusion Pumps
- Wound Care Products
- Inhalers
- Transdermal PatchesÂ
- Others
- By Application:
- Cardiovascular
- Non-Cardiovascular
- Urological
- Bone Treatment
- Antimicrobial treatment
- Cancer Treatment
- Ophthalmic TreatmentÂ
- Diabetes Treatment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug-Device Combination Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug-device combination products are medical devices that are used together to treat a disease or condition. The device may be a single item, such as a stent, or it may be part of an overall treatment plan, such as surgery and chemotherapy.
Some of the key players operating in the drug-device combination products market are Abbott, Boston Scientific Corporation, Cook Medical, Medtronic, Smith & Nephew, St. Jude Medical, Stryker Corporation, Zimmer, Ethicon, C.R. Bard.
The drug-device combination products market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug-Device Combination Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug-Device Combination Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug-Device Combination Products Market - Supply Chain
4.5. Global Drug-Device Combination Products Market Forecast
4.5.1. Drug-Device Combination Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug-Device Combination Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug-Device Combination Products Market Absolute $ Opportunity
5. Global Drug-Device Combination Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug-Device Combination Products Market Size and Volume Forecast by Type
5.3.1. Drug Eluting Stents
5.3.2. Photosensitizers
5.3.3. Orthopaedic products
5.3.4. Infusion Pumps
5.3.5. Wound Care Products
5.3.6. Inhalers
5.3.7. Transdermal Patches
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug-Device Combination Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug-Device Combination Products Market Size and Volume Forecast by Application
6.3.1. Cardiovascular
6.3.2. Non-Cardiovascular
6.3.3. Urological
6.3.4. Bone Treatment
6.3.5. Antimicrobial treatment
6.3.6. Cancer Treatment
6.3.7. Ophthalmic Treatment
6.3.8. Diabetes Treatment
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug-Device Combination Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug-Device Combination Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug-Device Combination Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug-Device Combination Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug-Device Combination Products Demand Share Forecast, 2019-2029
9. North America Drug-Device Combination Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug-Device Combination Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug-Device Combination Products Market Size and Volume Forecast by Application
9.4.1. Cardiovascular
9.4.2. Non-Cardiovascular
9.4.3. Urological
9.4.4. Bone Treatment
9.4.5. Antimicrobial treatment
9.4.6. Cancer Treatment
9.4.7. Ophthalmic Treatment
9.4.8. Diabetes Treatment
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug-Device Combination Products Market Size and Volume Forecast by Type
9.7.1. Drug Eluting Stents
9.7.2. Photosensitizers
9.7.3. Orthopaedic products
9.7.4. Infusion Pumps
9.7.5. Wound Care Products
9.7.6. Inhalers
9.7.7. Transdermal Patches
9.7.8. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug-Device Combination Products Demand Share Forecast, 2019-2029
10. Latin America Drug-Device Combination Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug-Device Combination Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug-Device Combination Products Market Size and Volume Forecast by Application
10.4.1. Cardiovascular
10.4.2. Non-Cardiovascular
10.4.3. Urological
10.4.4. Bone Treatment
10.4.5. Antimicrobial treatment
10.4.6. Cancer Treatment
10.4.7. Ophthalmic Treatment
10.4.8. Diabetes Treatment
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug-Device Combination Products Market Size and Volume Forecast by Type
10.7.1. Drug Eluting Stents
10.7.2. Photosensitizers
10.7.3. Orthopaedic products
10.7.4. Infusion Pumps
10.7.5. Wound Care Products
10.7.6. Inhalers
10.7.7. Transdermal Patches
10.7.8. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug-Device Combination Products Demand Share Forecast, 2019-2029
11. Europe Drug-Device Combination Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug-Device Combination Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug-Device Combination Products Market Size and Volume Forecast by Application
11.4.1. Cardiovascular
11.4.2. Non-Cardiovascular
11.4.3. Urological
11.4.4. Bone Treatment
11.4.5. Antimicrobial treatment
11.4.6. Cancer Treatment
11.4.7. Ophthalmic Treatment
11.4.8. Diabetes Treatment
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Appliction
11.7. Europe Drug-Device Combination Products Market Size and Volume Forecast by Type
11.7.1. Drug Eluting Stents
11.7.2. Photosensitizers
11.7.3. Orthopaedic products
11.7.4. Infusion Pumps
11.7.5. Wound Care Products
11.7.6. Inhalers
11.7.7. Transdermal Patches
11.7.8. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug-Device Combination Products Demand Share, 2019-2029
12. Asia Pacific Drug-Device Combination Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug-Device Combination Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug-Device Combination Products Market Size and Volume Forecast by Application
12.4.1. Cardiovascular
12.4.2. Non-Cardiovascular
12.4.3. Urological
12.4.4. Bone Treatment
12.4.5. Antimicrobial treatment
12.4.6. Cancer Treatment
12.4.7. Ophthalmic Treatment
12.4.8. Diabetes Treatment
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug-Device Combination Products Market Size and Volume Forecast by Type
12.7.1. Drug Eluting Stents
12.7.2. Photosensitizers
12.7.3. Orthopaedic products
12.7.4. Infusion Pumps
12.7.5. Wound Care Products
12.7.6. Inhalers
12.7.7. Transdermal Patches
12.7.8. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug-Device Combination Products Demand Share, 2019-2029
13. Middle East & Africa Drug-Device Combination Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug-Device Combination Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug-Device Combination Products Market Size and Volume Forecast by Application
13.4.1. Cardiovascular
13.4.2. Non-Cardiovascular
13.4.3. Urological
13.4.4. Bone Treatment
13.4.5. Antimicrobial treatment
13.4.6. Cancer Treatment
13.4.7. Ophthalmic Treatment
13.4.8. Diabetes Treatment
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug-Device Combination Products Market Size and Volume Forecast by Type
13.7.1. Drug Eluting Stents
13.7.2. Photosensitizers
13.7.3. Orthopaedic products
13.7.4. Infusion Pumps
13.7.5. Wound Care Products
13.7.6. Inhalers
13.7.7. Transdermal Patches
13.7.8. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug-Device Combination Products Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Drug-Device Combination Products Market: Market Share Analysis
14.2. Drug-Device Combination Products Distributors and Customers
14.3. Drug-Device Combination Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cook Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medtronic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Smith & Nephew
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. St. Jude Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Stryker Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zimmer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ethicon
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. C.R. Bard
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
&nb
